Clinical Trial Update: A Combination of Pazopanib and Carboplatin in Advanced Solid Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating pazopanib in combination with carboplatin for advanced metastatic solid malignancies; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Solid Tumors

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Pazopanib (Pazopanib)

Snippet

Sponsor: New Mexico Cancer Research Alliance | Conditions: Cancer, Metastatic | Phase 1 | Status: TERMINATED